Nanoparticles
AssigneeKing's College London
InventorsMaria Thanou, Michael James Lee Wright, Miguel Centelles, Andrew David Miller, Wladyslaw Gedroyc
Life of this patent
Estimating the term…
Loading patent…
AssigneeKing's College London
InventorsMaria Thanou, Michael James Lee Wright, Miguel Centelles, Andrew David Miller, Wladyslaw Gedroyc
Estimating the term…
The invention provides a (drug-containing) lipid nanoparticle with: (i) at least one phospholipid; (ii) at least one lysolipid; and (iii) at least one phospholipid comprising a hydrophilic polymer; and (iv) at least one structural lipid of formula (I) which has the following general structure: wherein R and R′ are long hydrocarbyl hydrophobic chains, Y is a linker element, and PHG is a polar head group described as large according to its van der Waals radius, and which is different from the phospholipid (i). The lipid nanoparticle can release a drug (or API) from within the lipid nanoparticle as a result of focused ultrasound (FUS) applied continuously, at least twice, to a desired part of the body to induce hyperthermia (an increase in temperature). FUS is applied after the lipid nanoparticle containing the drug has been administered to the live subject, and causes controlled release of the drug at the desired site of the body. Ultrasound is then halted, and the site of interest allowed to cool. Ultrasound is then applied again. Lipid nanoparticles can be labelled (for MRI, NIRF imaging), enabling real time monitoring of the drug in the human body. Imaging information can be used to direct and guide the nature of the FUS applied to the site of interest.
A thermosensitive lipid nanoparticle comprising:
Dependencies are inferred from the claim text.